Thrilled at launch of 🇦🇺 optimal care pathways for older people with #cancer #COSAASM2025
www.cancer.org.au/assets/pdf/o...

Honoured to receive NSW health research award for our nurse-led geriatric oncology model of care for older patients with #lungcancer Innovative sustainable models essential in translating evidence into practice @nsw-health.bsky.social

It’s Lung Cancer Awareness Month 💙. Research improves outcomes for the world’s deadliest cancer. The IASLC community works to conquer lung cancer every day. Help fund critical research and make an impact: https://bit.ly/4nBZ6HU

Quality of Decision-making at Oncology Multidisciplinary Team Meetings: A Structured Observational Study Multidisciplinary meetings (MDMs) are crucial in cancer care, with increasing attention on improving the quality of decision-making. Validated tools h…

Important to assess quality of decision making at MDMs. Is the patient voice being heard? Do nurses contribute? www.sciencedirect.com/science/arti...

59 - Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults - TOGA - Thoracic Oncology Group Australasia In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, the focus is on lung cancer in older adults.

Pleasure to be part of this podcast about treating older people with #lungcancer thoraciconcology.org.au/podcasts/59-... @togaanz.bsky.social @dkarikios.bsky.social @tomjohnston2796.bsky.social

Super session announcing a new @thelancet.com @iaslc.bsky.social Commission on lung cancer at this year’s WCLC 2025 in Barcelona

The IASLC - Lancet Commission on Lung Cancer The IASLC - Lancet Commission on Lung Cancer brings together leading clinicians, researchers, policymakers, and patient advocates from across the globe aiming to reframe the global lung cancer agenda.

Excited to be a commissioner for Lancet Commission on Lung Cancer www.lancetlungcancer.org @iaslc.bsky.social @thelancet.com

Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process - British Journal of Cancer British Journal of Cancer - Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process

Are you thinking of studying the association of the time from cancer diagnosis to treatment and overall survival? Have a look at these consensus recommendations we developed and published in the British Journal of Cancer:

www.nature.com/articles/s41...

3694 people enrolled for lung cancer screening in first month of lung cancer screening in 🇦🇺 👏🏽👏🏽👏🏽 @racgp.bsky.social @togaanz.bsky.social

Implementation and evaluation of a nurse-led geriatric oncology model of care for older adults with lung cancer

A #nurse led geriatric oncology model of care is a feasible way of ⬆️ geriatric screening & assessment of older adults with #cancer. www.sciencedirect.com/science/arti...

Australia Launches Lung Cancer Screening Program for Smokers Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial low-dose CT scans.

🙏🏽 @medacape.com for showcasing #lungcancer screening in 🇦🇺 www.medscape.com/viewarticle/...

Lung cancer screening in 🇦🇺is finally here! Amazing amount of work from multidisciplinary group & consumers. www.health.gov.au/our-work/nlcsp Need @racgp.bsky.social support to assess patients for eligibility. It’s time to ⬆️ survival from lung cancer! @dkarikios.bsky.social @drtomjohn.bsky.social

The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies. www.redjournal.org/article/S036...

Australia's deadliest cancer to get new screening program After years of lobbying from patients, the first ever national lung cancer screening program will roll out next month for people who have a significant history of smoking.

🙏🏽 ABC for shining the light on 🇦🇺 deadliest cancer. Bring on #lungcancer screening www.abc.net.au/news/2025-06... @abcnewsbot.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @bensolomon1.bsky.social

Need exercise physiologists as routine members of oncology team esp for survivorship care

👏🏽👏🏽👏🏽 work by PhD student Dr Kim-Lin Chiew - Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach - Clinical Oncology www.clinicaloncologyonline.net/article/S093... @gerryhanna.bsky.social

This presumes surgery is the best local treatment for all patients with Stage III NSCLC. What are the outcomes of those whose disease remained unresectable, and how do they compare with Pacific regimen?

Derek’s Story - Radiation Oncology Targeting Cancer A game-changing radiation therapy technique called SABR is offering hope to people living with lung cancer, like Derek Peffe

🇦🇺lung cancer screening coming 1st July. Guidelines state “ Suitability for lung cancer surgery should not be a contraindication for screening, as those with comorbidities can safely be Rx with radiotherapy (SABR) with minimal toxicities”. www.targetingcancer.com.au/dereks-story/ @racgp.bsky.social

ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy This document reviews the evidence supporting different imaging modalities and techniques used to evaluate patients with a history of lung cancer. It …

Guidance on appropriate imaging in FU after #lungcancer Rx. Highly variable in practice. Time for #commonsenseoncology www.sciencedirect.com/science/arti... @iaslc.bsky.social @astro-org.bsky.social @gerryhanna.bsky.social @drtomjohn.bsky.social @dkarikios.bsky.social @hannaradonc.bsky.social

FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study Our results suggest that a deep learning model can estimate biological age from face photographs and thereby enhance survival prediction in patients with cancer. Further research, including validation...

Fascinating research on how a simple photo can be used to predict survival in cancer patients. FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study www.thelancet.com/journals/lan...

Psychosocial impacts of, and barriers to, lung cancer screening: an international qualitative study of multidisciplinary health professionals’ perspectives Many lung cancer screening (LCS) programs are in development following landmark trials demonstrating the effectiveness of screening for reducing lung …

Great work @nicoleranski.bsky.social on psychosocial influencers & barriers for #lungcancer screening www.sciencedirect.com/science/arti...

Sydney researchers awarded new funding for clinical trials and cohort studies University of Sydney medicine and health researchers awarded over $8 million under the National Health and Medical Research Council Clinical Trials and Cohort Studies grant scheme.

Excited to obtain funding for #radiotherapy RCT of functional lung avoidance in lung cancer radiotherapy www.sydney.edu.au/news-opinion... @sydney.edu.au

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer - OncoDaily TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer / cancer, ESTRO, ESTRO 2025, gastric cancer, Headlines, Leong

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer
@estroradiotherapy.bsky.social

oncodaily.com/opinion/topg...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025 #GastricCancer #TOPGEAR #CRT #GEJ

🇦🇺 guidelines for #lungcancer screening. Screening coming 1st July. Great step forward in #lungcancer Mx. Spread the word. www.health.gov.au/our-work/nlc... @newsgp.bsky.social @ausgov.bsky.social @drtomjohn.bsky.social @bensolomon1.bsky.social @dkarikios.bsky.social

Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy - PubMed The novel hybrid automatic segmentation tool reported high accuracy and consistency over a validation set with challenging anatomical and imaging variations. This has promising applications in substru...

👏🏽🎉Dr Vicky Chin on being awarded the Frank Ellis medal for greatest contribution to advancing the science of cancer
treatment in 2023 Clinical Oncology. pubmed.ncbi.nlm.nih.gov/36964031/ @unsw.bsky.social @gerryhanna.bsky.social #Cardiooncology #PhD

@hannaradonc.bsky.social

Clinicians have their own specialty bias for Rx on NSCLC. Hardly surprising but how can we ensure balanced opinions for patients? Should they see all treating specialists? www.sciencedirect.com/science/arti... @iaslc.bsky.social @patientadvocacy.bsky.social

Health Care Contact Days for NSCLC Treated in Clinical Trials vs Routine Care This cohort study examines patterns of contact days among patients with advanced-stage non–small cell lung cancer receiving care in clinical trials compared with routine practice.

Clinical trials of systemic Rx in NSCLC NOT assoc with time toxicity in Canada! jamanetwork.com/journals/jam...

Surveillance with [18F]FDG PET/CT of stage I-III lung cancer patients after completion of curative treatment (SUPE_R): a randomized controlled trial Post-treatment surveillance is recommended for non-small cell lung cancer (NSCLC) due to a high risk of recurrence, but evidence on the optimal survei…

Surveillance with FDG PET/CT does not improve rates of curatively treated recurrences, TTR, or OS compared to ceCT in NSCLC patients after curative treatment.
www.sciencedirect.com/science/arti...

Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guideline The incidence of radiation pneumonitis (RP) has decreased significantly compared to historical series, mainly due to improved radiotherapy techniques …

Guideline on Dx & Rx of radiation pneumonitis. Hope to investigate functional lung RT planning to limit this toxicity. www.sciencedirect.com/science/arti... @drdavidpalma.bsky.social